Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
2 Unstoppable Artificial Intelligence (AI) Stocks to Buy in April and 1 to Avoid
While two AI leaders with undeniable competitive moats are historically cheap, another Wall Street darling is staring down a ...
Google replaces the leader of its consumer AI apps: report
Google reshuffles AI leadership with Sissie Hsiao stepping down and Josh Woodward stepping in to drive Gemini's evolution.
Alphabet: Progress In AI Cannot Be Ignored For Long
Alphabet's recent AI progress and Waymo expansion signal growth potential. Learn why GOOG stock is trading cheap and could be ...
BioPharma Dive2d
Isomorphic raises $600M on big ambitions for AI drugmaking tech
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
Alphabet Inc. (GOOG): Among the Best US Stocks to Buy For Foreign Investors
We recently published a list of 10 Best US Stocks To Buy For Foreign Investors. In this article, we are going to take a look ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet (NASDAQ:GOOG) on Tuesday with a Buy rating and a price ...